60518-59-4

Basic information

• Product Name: 2-METHYL-2H-INDAZOL-5-AMINE
• Synonyms: 2-METHYL-2H-INDAZOL-5-AMINE;5-Amino-2-methyl-2H-indazole;2-METHYL-2H-INDAZOL-5-YLAMINE;2-methyl-2H-indazole-5-amine;5-Amino-2-methylindazole;2H-Indazol-5-aMine, 2-Methyl-
• CAS NO: 60518-59-4
• Molecular Formula: C₈H₉N₃
• Molecular Weight: 147.18
• Mol File: 60518-59-4.mol
• Article Data: 8

Chemical Properties

• Melting Point: 125
• Boiling Point: 354.8°C at 760 mmHg
• Flash Point: 168.4°C
• Appearance: /
• Density: 1.27g/cm³
• Vapor Pressure: 3.26E-05mmHg at 25°C
• Refractive Index: 1.667
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 3.65±0.10(Predicted)
• CAS DataBase Reference: 2-METHYL-2H-INDAZOL-5-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-METHYL-2H-INDAZOL-5-AMINE(60518-59-4)
• EPA Substance Registry System: 2-METHYL-2H-INDAZOL-5-AMINE(60518-59-4)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 60518-59-4(Hazardous Substances Data)

Usage

General Description

2-Methyl-2H-indazol-5-amine is a chemical compound with the molecular formula C8H9N3. It is a derivative of indazole, a heterocyclic compound containing a benzene ring fused to a five-membered nitrogen-containing ring. 2-Methyl-2H-indazol-5-amine has potential application in pharmaceutical and medicinal chemistry, possibly in the development of new drugs or as a precursor in organic synthesis. Its specific properties and potential uses would depend on further research and development in the field of chemistry and pharmacology.

InChI:InChI=1/C8H9N3/c1-11-5-6-4-7(9)2-3-8(6)10-11/h2-5H,9H2,1H3

Upstream product

• 5228-48-8 2-methyl-5-nitro-2H-indazole 
• 5401-94-5 5-nitroindazole 
• 65750-01-8 5-nitro-2H-indazole 

Relevant articles and documents

INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1

The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compou

HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions in need of inhibition of heparan sulfate biosynthesis.

THIENO[3,2-D]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES

Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.